DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Epithelioid sarcoma
Epithelioid sarcoma
SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma
National Cancer Grid Management of Bone and Soft Tissue Tumors
Epithelioid Sarcoma Expresses Epidermal Growth Factor Receptor but Gene Amplification and Kinase Domain Mutations Are Rare
First EZH2 Inhibitor Approved—For Rare Sarcoma
Olaratumab and Doxorubicin for the Treatment of Metastatic Soft Tissue Sarcoma: a Retrospective Case Series
1 an Update on Ancillary Techniques in the Diagnosis of Soft Tissue Tumors
Identification, by Systematic RNA Sequencing, of Novel Candidate
Primary Pulmonary Epithelioid Sarcoma: a Case Report Eiki Mizutani1*, Riichiro Morita1, Keiko Abe2, Makoto Kodama2, Shogo Kasai3, Yasumi Okochi3 and Noriko Motoi4
November 18 - 21, 2020
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma
A Rare Case of Metastatic Proximal-Type Epithelioid Sarcoma of the Ischioanal Fossa: Case Report and Literature Review
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
Primary Pleural Epithelioid Sarcoma of the Proximal Type: a Diagnostic and Therapeutic Challenge
A Comparative Genomic Hybridization Study Tamara Lushnikova, M.D., Sakari Knuutila, Ph.D., Markku Miettinen, M.D
SMARCB1/INI1-Deficient Tumors of Adulthood[Version 2; Peer Review: 2
Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor? William Swalchick, MA, Rania Shamekh, MD, and Marilyn M
Candidate Biomarkers for Specific Intraoperative Near-Infrared
Top View
Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
Molecular Biology of Sarcoma
In Children with Recurrent Solid Tumors: a Children's Oncology Group Phase I Consortium Report Maryam Fouladi1, John P
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma Priya Chudasama1, Marcus Renner2, Melanie Straub3, Sadaf S
Expression Profile and Molecular Genetic Regulation of Cyclin D1 Expression in Epithelioid Sarcoma
Soft Tissue Sarcoma)
Histone Deacetylase Inhibitor Panobinostat Induces Antitumor
Translating Molecular Profiling of Soft Tissue Sarcomas Into Daily Clinical
Primary Epithelioid Sarcoma of the Vulva in Pregnancy
Epithelioid Sarcoma Resembling Benign Fibrous Histiocytoma
Tumor Response to Temsirolimus for Epithelioid Angiomyolipoma and Novel Mutation of SMARCB1/INI1 Tumor Suppressor Gene
The Rapidly Expanding Group of RB1-Deleted Soft Tissue Tumors: an Updated Review
Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis
Soft Tissue and Bone Sarcoma
Combining EGFR and Mtor Blockade for the Treatment of Epithelioid Sarcoma
Systemic Treatment in Advanced Soft Tissue Sarcoma: What Is Standard, What Is New Anna Maria Frezza1, Silvia Stacchiotti1 and Alessandro Gronchi2*
Epithelioid Sarcoma Is Associated with a High Percentage of SMARCB1
Immunotherapy for Sarcomas: New Frontiers and Unveiled Opportunities
Apatinib for Advanced Sarcoma: Results from Multiple Institutions' Off
Frequent Absence of Tumor Suppressor FUS1 Protein Expression in Human Bone and Soft Tissue Sarcomas
Managing Adult Soft Tissue Sarcomas and Gastrointestinal Stromal Tumours
NCCN Patient Guideline for Soft Tissue Sarcoma
Facts and Hopes in Immunotherapy of Soft Tissue Sarcomas
Epidermal Growth Factor Receptor Expression and Mutational Analysis in Synovial Sarcomas and Malignant Peripheral Nerve Sheath Tumors
Epithelioid Sarcoma: an Unusual Presentation in the Distal Phalanx of the Toe